Start-up stories: From science to business

Their first pitch deck didn’t contain a business slide. And there wasn’t any information on market potential. These were things that Dr Isabel Schellinger and Dr Uwe Raaz simply hadn’t thought of. After all, their focus was on their research, on the amazing opportunities made possible thanks to science, and on a medical solution to an aortic disorder in humans that they had developed. This is their passion and their field of expertise. Pitching to investors and founding a start-up were things that they first needed to learn.

Today, the two of them are successfully running their medtech start-up Angiolutions, a HTGF portfolio company that was founded in 2020 in the middle of the pandemic. The two doctors conducted research together at Stanford. Building on their research work, they came up with the idea of a novel vascular implant to treat aortic aneurysms. The aorta plays an absolutely vital role, carrying oxygen-rich blood from the heart to the rest of the body. It has a diameter of 2.5 to 3.5cm. If the aorta becomes enlarged and then bulges, it can present a major risk. This is known as an aneurysm. If the aorta tears or bursts, it can be life-threatening. A bulging aorta is like a ticking time bomb, with its diameter increasing by around 2.5mm per year. Around 4-8 percent of men around the world suffer from abdominal aortic aneurysms.

Thanks to Angiolutions’s device-based therapy, doctors now for the first time have access to a minimally invasive, low-risk treatment option that prevents small aortic aneurysms from growing in size.

In this episode of our “Start-up stories” series of short videos, Dr Isabel Schellinger and Dr Uwe Raaz tell us about their journey into the world of business and offer some tips on founding a start-up in the field of science. Here’s a little teaser of what they have to say: As is so often the case, the key is to identify a genuine medical need or a genuine customer need. Get support from good partners. And don’t forget to put a business slide in your pitch deck.

A big thank you to Isabel and Uwe for all their insights!

Are you a medtech entrepreneur or looking to found a start-up in this field? Share your experiences and ideas with Principal Anke Caßing. She looks forward to hearing from you.

More Blog posts

12. January 2023

MedTech Pitch Day 2023: Connecting Startups with Industry Leaders, Investors, and Decision-Makers

The MedTech Pitch Day, organised by HTGF, Dräger, B.Braun, Techniker Krankenkasse and the Health Innovation Port, is just around the corner. What can founders expect at the event and why should they definitely apply? We spoke to Anke Cassing, Principal at HTGF, and Jakob Lilienweiss, Investment Analyst at HTGF, to find out. The MedTech Pitch Day will take place on March 29th in Berlin. Can you tell us more about the event and what founders can expect? Anke: The event has develop
20. December 2022

2022 – High-Tech Gründerfonds end-of-year review

We’d like to begin this end-of-year review by saying thank you to all those who support us, enable us to do our work and place their trust in us. This particularly applies to the founders, numerous co-investors and shareholders of our portfolio companies as well as our fund investors. This year saw the launch of our fourth fund, HTGF IV, which more than 40 private companies have invested in alongside the Federal Ministry for Economic Affairs and Climate Action and KfW Capital. Among t
19. December 2022

2022 review and 2023 preview from our investment teams

What opportunities and challenges did we face in 2022? And what trends and technologies can we expect to see next year? Our three investment teams – industrial tech, life sciences & chemistry, and digital tech – reflect on an eventful year and look ahead to 2023. Industrial tech The effects of the climate crisis continue to place huge challenges on society. HTGF aims to be part of the solution. Since 2005, we have invested in around 60 climate tech companies and are well-placed